Search

Your search keyword '"Goria, O"' showing total 165 results

Search Constraints

Start Over You searched for: Author "Goria, O" Remove constraint Author: "Goria, O"
165 results on '"Goria, O"'

Search Results

1. A Novel 8-Predictors Signature to Predict Complicated Disease Course in Pediatric-onset Crohn’s Disease: A Population-based Study

2. Impact of Extra-Intestinal Manifestations at Diagnosis on Disease Outcome in Pediatric- and Elderly-Onset Crohn′s Disease: A French Population-Based Study

4. Ulcerative proctitis is a frequent location of paediatric-onset UC and not a minor disease: a population-based study

6. 1007P cfDNA and ctDNA variations are predictive of disease progression to conventional transarterial chemoembolization (cTACE) in patients with hepatocellular carcinoma (HCC)

12. Estimated risk reduction of mortality and transplantation with bezafibrate in patients with PBC and inadequate response to UDCA: application of the UK-PBC and Global PBC risk scores to the BEZURSO trial

14. Dramatic Increase in Incidence of Ulcerative Colitis and Crohn's Disease (1988–2011): A Population-Based Study of French Adolescents

15. Changes in serum bile acid levels associated with bezafibrate add-on therapy in patients with primary biliary cholangitis and inadequate biochemical response to ursodeoxycholic acid: results from the BEZURSO trial (NCT01654731)

18. Treatment and prognosis of acute severe autoimmune hepatitis

19. A 2-year multicenter, double-blind, randomized, placebo-controlled study of bezafibrate for the treatment of primary biliary cholangitis in patients with inadequate biochemical response to ursodeoxycholic acid therapy (Bezurso)

20. HEP-10 - Bilan d’une année de RCP hépatite C

22. Epidémie d'hépatite A aiguë parmi des hommes ayant des rapports sexuels avec des hommes (HSH) Caractéristiques cliniques et épidémiologiques des cas diagnostiqués au CHU de Rouen

24. PS-001 - Estimated risk reduction of mortality and transplantation with bezafibrate in patients with PBC and inadequate response to UDCA: application of the UK-PBC and Global PBC risk scores to the BEZURSO trial

26. G08 : Incidence of hepatocellular carcinoma (HCC) and complications in alcoholic compensated cirrhosis. Preliminary results of a multicenter prospective French and belgian cohort (INCA Cirral)

28. P1288 : Budd chiari syndrome (BCS) in France from a large national cohort

30. LBO-01 - A 2-year multicenter, double-blind, randomized, placebo-controlled study of bezafibrate for the treatment of primary biliary cholangitis in patients with inadequate biochemical response to ursodeoxycholic acid therapy (Bezurso)

31. PS-001 - Treatment and prognosis of acute severe autoimmune hepatitis

32. P497 DIRECT SEQUENCING OF PROTEIN-C AND -S GENES IN PATIENTS WITH BUDD–CHIARI SYNDROME (BCS), PORTAL-VEIN THROMBOSIS (PVT) AND OBLITERATIVE-PORTAL-VENOPATHY (OPV) AND SUSPICION OF INHERITED PROTEIN-C OR -S DEFICIENCY

33. O69 ALBUMIN INFUSION FOR BACTERIAL INFECTIONS OTHER THAN SPONTANEOUS BACTERIAL PERITONITIS IN CIRRHOTIC PATIENTS: A MULTICENTER RANDOMIZED CONTROLLED STUDY (ALB-CIRINF STUDY)

34. Le traitement cytoréducteur améliore la survie sans complication des patients suivis pour un syndrome myéloprolifératif associé à une thrombose veineuse hépatosplanchnique

36. 83 TREATMENT OF SEVERE ACUTE ALCOHOLIC HEPATITIS (AAH) WITH CORTICOIDS PLUS N-ACETYL CYSTEINE (C+NAC) VERSUS CORTICOIDS ALONE (C): A MULTICENTRE, RANDOMIZED, CONTROLLED TRIAL

37. 246 ASSESSMENT OF PAROXETINE IN THE PREVENTION OF DEPRESSION IN PATIENTS WITH CHRONIC HEPATITIS C TREATED BY PEG-INTERFERON-RIBAVIRIN.: A DOUBLE-BLINDED, RANDOMIZED STUDY. ANRS HC18 PAROPEG

38. 390 TRENDS IN EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS OF HCV-INFECTED PATIENTS OVER SIX YEARS: A FRENCH EXPERIENCE

40. 38 TREATMENT OF SEVERE ACUTE ALCOHOLIC HEPATITIS (AAH) WITH CORTICOIDS PLUS N-ACETYL CYSTEINE (C-NAC) VERSUS CORTICOIDS (C): PLANED INTERIM ANALYSIS OF A MULTICENTRE, CONTROLLED, RANDOMIZED TRIAL

41. C028 - Est-ce que l’amantadine améliore la réponse virologique long terme de l’association Peg-Interféron-alpha2b/ribavirine chez les malades atteints d’hépatite chronique C n’ayant jamais reçu de traitement ? Étude prospective randomisée multicentrique en double aveugle : résultats préliminaires chez 200 malades

Catalog

Books, media, physical & digital resources